Shareholders of these three health-care stocks could be wishing for a do-over for the start of July.
One of the week's big losers appears to have been hurt by being dropped from a well-known index. Another reported late-stage clinical study results that caused some to worry. And the third was stung by the posting of a warning letter by the U.S. Food and Drug Administration.
Which three health-care stocks were crushed by the market this week? Find out by watching the slideshow below.
This coming blockbuster could help you crush the market
The best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool's new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.
Keith Speights owns shares of Apple. The Motley Fool recommends Apple, Google (A shares), Google (C shares), and Netflix. The Motley Fool owns shares of Apple, Google (A shares), Google (C shares), and Netflix. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.